DW Healthcare Partners has successfully sold LKC Technologies to AMETEK, Inc., enhancing the latter's portfolio in innovative diagnostic solutions for retinal assessments.

Target Information

DW Healthcare Partners recently announced the sale of LKC Technologies to AMETEK, Inc. LKC Technologies is recognized as a leader in visual electrophysiology, dedicated to enhancing sight preservation by providing access to objective functional retinal assessments. With over 35 years of innovation in diagnostic technology, the company has simplified complex visual electrophysiology into intuitive solutions for clinicians and researchers globally.

The hallmark of LKC's offering is its handheld, non-invasive electroretinography (ERG) device, the RETeval, which provides reliable and objective data essential for diagnosing and managing retinal and optic nerve diseases. LKC Technologies is committed to improving patient outcomes and offers advanced tools and exceptional customer service to eye care professionals, thereby accelerating clinical care and research. Dina Dubey, CEO of LKC Technologies, expressed gratitude to DWHP for their support over the last three years, acknowledging the significant contributions to the company's growth.

Industry Overview in the Healthcare Sector

The healthcare industry has been rapidly evolving, particularly in the realm of diagnostic technology aimed at addressing critical medical issues. Countries with advanced healthcare systems have witnessed a growing demand for accurate diagnostic